Identification of patient profile for treatment

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 28, Issue 6, 2014, Pages 767-782

  Moon, Rebecca J ^a,b   Harvey, Nicholas C ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bone mineral density; Epidemiology; Fracture; FRAX; Garvan; Osteoporosis; Probability; QFracture

Indexed keywords

GLUCOCORTICOID;

ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; COMPUTER PROGRAM; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HIGH RISK POPULATION; HUMAN; OSTEOPOROSIS; PATIENT IDENTIFICATION; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; FRACTURES, BONE; PHYSIOLOGY; PROCEDURES; RISK MANAGEMENT;

BONE DENSITY; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; RISK MANAGEMENT;

EID: 84927962496     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2014.04.005     Document Type: Review

References (87)

1. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94 (6) : 646-50.
2. Hernlund E, Svedbom A, Ivergard M, et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) . Archives Osteoporos 2013; 8 (1, 2) : 136. http://dx.doi.org/10.1007/s11657-013-0136-1.
3. Kanis JA, Oden A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 2012; 23 (9) : 2239-56. http://dx.doi.org/10.1007/s00198-012-1964-3.
4. Litwic A, Edwards M, Cooper C, et al. Geographic differences in fractures among women. Women's Health (London, England) 2012; 8 (6) : 673-84. http://dx.doi.org/10.2217/whe.12.54.
5. Cooper C, Campion G, Melton III LJ. Hip fractures in the elderly: A world-wide projection. Osteoporos Int 1992; 2 (6) : 285-9
6. Cooper C, Cole ZA, Holroyd CR, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 2011; 22 (5) : 1277-88. http://dx.doi.org/10.1007/s00198-011-1601-6 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
7. Morin SN, Lix LM, Majumdar SR, et al. Temporal trends in the incidence of osteoporotic fractures. Curr Osteoporos Reports 2013; 11 (4) : 263-9. http://dx.doi.org/10.1007/s11914-013-0168-x.
8. Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009; 301 (5) : 513-21.
9. Haentjens P, Magaziner J, Colon-Emeric CS, et al. Meta-analysis: Excess mortality after hip fracture among older women and men. Ann Intern Med 2010; 152 (6) : 380-90. http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00008.
10. Abrahamsen B, van Staa T, Ariely R, et al. Excess mortality following hip fracture: A systematic epidemiological review. Osteoporos Int 2009; 20 (10) : 1633-50. http://dx.doi.org/10.1007/s00198-009-0920-3 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
11. Wehren LE, Hawkes WG, Orwig DL, et al. Gender differences in mortality after hip fracture: The role of infection. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2003; 18 (12) : 2231-7. http://dx.doi.org/10.1359/jbmr.2003.18.12.2231.
12. Roche JJ, Wenn RT, Sahota O, et al. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study. BMJ 2005; 331 (7529) : 1374. http://dx.doi.org/10.1136/bmj. 38643.663843.55.
13. Adachi JD, Adami S, Gehlbach S, et al. Impact of prevalent fractures on quality of life: Baseline results from the global longitudinal study of osteoporosis in women. Mayo Clinic proceedings. Mayo Clin 2010; 85 (9) : 806-13. http://dx.doi.org/10.4065/mcp.2010.0082.
14. Kim SM, Moon YW, Lim SJ, et al. Prediction of survival, second fracture, and functional recovery following the first hip fracture surgery in elderly patients. Bone 2012; 50 (6) : 1343-50. http://dx.doi.org/10.1016/j.bone.2012.02.633.
15. Leibson CL, Tosteson AN, Gabriel SE, et al. Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study. J Am Geriatrics Soc 2002; 50 (10) : 1644-50.
16. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35 (2) : 375-82. http://dx.doi.org/10.1016/j.bone.2004.03.024.
17. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2000; 15 (4) : 721-39. http://dx.doi.org/10.1359/jbmr.2000.15.4.721.
18. Gehlbach S, Saag KG, Adachi JD, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: The Global Longitudinal Study of Osteoporosis inWomen. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2012; 27 (3) : 645-53. http://dx.doi.org/10.1002/jbmr.1476.
19. Costa AG, Wyman A, Siris ES, et al. When, where and how osteoporosis-associated fractures occur: An analysis from the global longitudinal study of osteoporosis in women (GLOW) . PloS One 2013; 8 (12) : E83306. http://dx.doi.org/10.1371/journal.pone.0083306.
20. Sambrook P, Cooper C. Osteoporos Lancet 2006; 367 (9527) : 2010-8. http://dx.doi.org/10.1016/s0140-6736 (06) 68891-0.
21. Cooper C, Dennison EM, Leufkens HG, et al. Epidemiology of childhood fractures in Britain: A study using the general practice research database. J Bone Miner Res. 2004; 19 (12) : 1976-81. http://dx.doi.org/10.1359/JBMR.040902.
22. van Staa TP, Dennison EM, Leufkens HG, et al. Epidemiology of fractures in England and Wales. Bone 2001; 29 (6) : 517-22.
23. Hansen S, Shanbhogue V, Folkestad L, et al. Bone microarchitecture and estimated strength in 499 adult Danish women and men: A cross-sectional, population-based high-resolution peripheral quantitative computed tomographic study on peak bone structure. Calcif Tissue Int 2014 Mar; 94 (3) : 269-81. http://dx.doi.org/10.1007/s00223-013-9808-5.
24. Macdonald HM, Nishiyama KK, Kang J, et al. Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: A population-based HR-pQCT study. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2011; 26 (1) : 50-62. http://dx.doi.org/10.1002/jbmr.171.
25. Seeman E. Bone quality: The material and structural basis of bone strength. J Bone Mineral Metabolism 2008; 26 (1) : 1-8. http://dx.doi.org/10.1007/s00774-007-0793-5.
26. ZebazeRM,Ghasem-ZadehA, Bohte A, et al. Intracortical remodelling and porosity in the distal radius and post-mortemfemurs of women: A cross-sectional study. Lancet 2010; 375 (9727) : 1729-36. http://dx.doi.org/10.1016/s0140-6736 (10) 60320-0.
27. Svejme O, Ahlborg HG, Nilsson JA, et al. Early menopause and risk of osteoporosis, fracture and mortality: A 34-year prospective observational study in 390 women. BJOG: Int J Obstetrics Gynaecol 2012; 119 (7) : 810-6. http://dx.doi.org/10.1111/j.1471-0528.2012.03324.x.
28. Stenhagen M, Ekstrom H, Nordell E, et al. Falls in the general elderly population: A 3-and 6-year prospective study of risk factors using data from the longitudinal population study 'Good ageing in Skane'. BMC Geriatr 2013; 13: 81. http://dx.doi.org/10.1186/1471-2318-13-81.
29. Wright NC, Saag KG, Curtis JR, et al. Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2012; 27 (11) : 2325-32. http://dx.doi.org/10.1002/jbmr.1684.
30. Looker AC, Melton III LJ, Harris TB, et al. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2010; 25 (1) : 64-71. http://dx.doi.org/10.1359/jbmr.090706.
31. Putman MS, Yu EW, Lee H, et al. Differences in skeletal microarchitecture and strength in African-American and white women. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2013; 28 (10) : 2177-85. http://dx.doi.org/10.1002/jbmr.1953.
32. Benetou V, Orfanos P, Benetos IS, et al. Anthropometry, physical activity and hip fractures in the elderly. Injury 2011; 42 (2) : 188-93. http://dx.doi.org/10.1016/j.injury.2010.08.022.
33. De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int 2005; 16 (11) : 1330-8. http://dx.doi.org/10.1007/s00198-005-1863-y [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
34. Johansson H, Kanis JA, Oden A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2014; 29 (1) : 223-33. http://dx.doi.org/10.1002/jbmr.2017.
35. Compston JE, Watts NB, Chapurlat R, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011; 124 (11) : 1043-50. http://dx.doi.org/10.1016/j.amjmed.2011.06.013.
36. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. New Engl J Med 1995; 332 (12) : 767-73. http://dx.doi.org/10.1056/nejm199503233321202.
37. Slemenda CW, Christian JC, Williams CJ, et al. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Mineral Res Off J Am Soc Bone Mineral Res 1991; 6 (6) : 561-7. http://dx.doi.org/10.1002/jbmr.5650060606.
38. Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1987; 80 (3) : 706-10. http://dx.doi.org/10.1172/jci113125.
39. Dennison EM, Arden NK, Keen RW, et al. Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatr Perinat Epidemiol 2001; 15 (3) : 211-9.
40. Ferrari SL, Karasik D, Liu J, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2004; 19 (4) : 552-9. http://dx.doi.org/10.1359/jbmr.040103.
41. Antoniades L, MacGregor AJ, Andrew T, et al. Association of birth weight with osteoporosis and osteoarthritis in adult twins. Rheumatol Oxf JID-100883501 2003; 42 (6) : 791-6.
42. Frost M, Petersen I, Andersen TL, et al. Birth weight and adult bone metabolism are unrelated: Results from birth weightdiscordant monozygotic twins. J Bone Min Res 2013; 28 (12) : 2561-9. http://dx.doi.org/10.1002/jbmr.1995.
43. Holroyd C, Harvey N, Dennison E, et al. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int 2012; 23 (2) : 401-10. http://dx.doi.org/10.1007/s00198-011-1671-5 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
44. Steinbuch M, Youket T, Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 2004; 15 (4) : 323-8. http://dx.doi.org/10.1007/s00198-003-1548-3.
45. van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses. Rheumatol Oxf Engl 2000; 39 (12) : 1383-9.
46. Van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2000; 15 (6) : 993-1000. http://dx.doi.org/10.1359/jbmr.2000.15.6.993.
47. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2004; 19 (6) : 893-9. http://dx.doi.org/10.1359/jbmr.040134.
48. Van Staa TP, Laan RF, Barton IP, et al. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheumatism 2003; 48 (11) : 3224-9. http://dx.doi.org/10.1002/art.11283.
49. Manolagas SC. Steroids and osteoporosis: The quest for mechanisms. J Clin Invest 2013; 123 (5) : 1919-21. http://dx.doi.org/10.1172/jci68062.
50. Dalle Carbonare L, Arlot ME, Chavassieux PM, et al. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2001; 16 (1) : 97-103. http://dx.doi.org/10.1359/jbmr.2001.16.1.97.
51. Khalili H, Huang ES, Jacobson BC, et al. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: A prospective cohort study. BMJ 2012; 344: E372. http://dx.doi.org/10.1136/bmj.e372.
52. Bazelier MT, de Vries F, Vestergaard P, et al. Risk of fracture with thiazolidinediones: An individual patient data metaanalysis. Front Endocrinol 2013; 4: 11. http://dx.doi.org/10.3389/fendo.2013.00011.
53. Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: A meta-analysis. CMAJ: Can Med Assoc J = journal de l'Association medicale canadienne 2009; 180 (1) : 32-9. http://dx.doi.org/10.1503/cmaj.080486.
54. Rizzoli R, Cooper C, Reginster JY, et al. Antidepressant medications and osteoporosis. Bone 2012; 51 (3) : 606-13. http://dx.doi.org/10.1016/j.bone.2012.05.018.
55. Nicholas JM, Ridsdale L, Richardson MP, et al. Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: Cohort study using the general practice research database. Seizure: J Br Epilepsy Assoc 2013; 22 (1) : 37-42. http://dx.doi.org/10.1016/j.seizure.2012.10.002.
56. Dennison EM, Compston JE, Flahive J, et al. Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW) . Bone 2012; 50 (6) : 1288-93. http://dx.doi.org/10.1016/j.bone.2012.02.639.
57. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: A meta-analysis. Osteoporos Int 2005; 16 (2) : 155-62. http://dx.doi.org/10.1007/s00198-004-1640-3 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
58. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16 (7) : 737-42. http://dx.doi.org/10.1007/s00198-004-1734-y [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
59. Grover ML, Edwards FD, Chang YH, et al. Fracture risk perception study: Patient self-perceptions of bone health often disagree with calculated fracture risk. Women's Health Issues: Off Publ Jacobs Inst Women's Health 2014; 24 (1) : E69-75. http://dx.doi.org/10.1016/j.whi.2013.11.007.
60. Gregson CL, Dennison EM, Compston JE, et al. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int 2014; 25 (1) : 85-95. http://dx.doi.org/10.1007/s00198-013-2438-y [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
61. Eisman JA, Bogoch ER, Dell R, et al. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Min Res 2012; 27 (10) : 2039-46. http://dx.doi.org/10.1002/jbmr.1698.
62. Akesson K, Marsh D, Mitchell PJ, et al. Capture the Fracture: A best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 2013; 24 (8) : 2135-52. http://dx.doi.org/10.1007/s00198-013-2348-z.
63. Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24 (1) : 23-57. http://dx.doi.org/10.1007/s00198-012-2074-y.
64. Lekamwasam S, Adachi JD, Agnusdei D, et al. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 2012; 23 (9) : 2257-76. http://dx.doi.org/10.1007/s00198-012-1958-1.
65. Lekamwasam S, Adachi JD, Agnusdei D, et al. An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Archives Osteoporos 2012; 7 (1-2) : 25-30. http://dx.doi.org/10.1007/s11657-012-0070-7.
66. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312 (7041) : 1254-9.
67. Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metabol 2005; 90 (5) : 2787-93. http://dx.doi.org/10.1210/jc.2004-1568.
68. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18 (8) : 1033-46. http://dx.doi.org/10.1007/s00198-007-0343-y.
69. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19 (4) : 385-97. http://dx.doi.org/10.1007/s00198-007-0543-5.
70. Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: Prospective open cohort study. BMJ 2012; 344: E3427. http://dx.doi.org/10.1136/bmj.e3427.
71. Kanis JA, Johansson H, Oden A, et al. Worldwide uptake of FRAX. Arch Osteoporos 2014; 9 (1) : 166. http://dx.doi.org/10. 1007/s11657-013-0166-8.
72. Leslie WD, Morin S, Lix LM, et al. Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int 2012; 23 (1) : 75-85. http://dx.doi.org/10.1007/s00198-011-1747-2 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
73. Olmez Sarikaya N, Kapar Yavasi S, Tan G, et al. Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey. Clin Rheumatol; 2014. http://dx.doi.org/10.1007/s10067-014-2491-8 [Epub ahead of print].
74. Kanis JA, Johansson H, Oden A, et al. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 2011; 22 (3) : 809-16. http://dx.doi.org/10.1007/s00198-010-1524-7 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
75. Kanis JA, Hans D, Cooper C, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int 2011; 22 (9) : 2395-411.
76. Leslie WD, Lix LM, Johansson H, et al. Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Min Res 2012; 27 (6) : 1243-51. http://dx.doi.org/10.1002/jbmr.1582.
77. Nguyen ND, Frost SA, Center JR, et al. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 2008; 19 (10) : 1431-44. http://dx.doi.org/10.1007/s00198-008-0588-0.
78. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: Prospective derivation and validation of QFractureScores. BMJ 2009; 339: B4229.
79. Cooper C, Harvey NC. Osteoporosis risk assessment. BMJ 2012; 344: E4191. http://dx.doi.org/10.1136/bmj.e4191.
80. Leslie WD, Schousboe JT. A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world. Curr Osteoporos Reports 2011; 9 (3) : 129-40. http://dx.doi.org/10.1007/s11914-011-0060-5.
81. National Osteoporosis Foundation. Clinician's guide to the prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2013. Available from http://nof.org/hcp/clinicians-guide.
82. Compston J, Bowring C, Cooper A, et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update. Maturitas 2013; 2013. http://dx.doi.org/10.1016/j. maturitas.2013.05.013.
83. McCloskey EV, Johansson H, Oden A, et al. Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 2009; 20 (5) : 811-7. http://dx.doi.org/10.1007/s00198-008-0786-9 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
84. McCloskey EV, Johansson H, Oden A, et al. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. J Bone Mineral Res Off J Am Soc Bone Mineral Res 2012; 27 (7) : 1480-6. http://dx.doi.org/10.1002/jbmr.1606.
85. Fiore CE, Gaudio A. When the FRAX ( (R) ) test is applied to controlled clinical trials. Clinical Cases Mineral Bone Metabol Off J Italian Soc Osteoporosis Mineral Metabolism Skeletal Dis 2012; 9 (3) : 135-7.
86. Shepstone L, Fordham R, Lenaghan E, et al. A pragmatic randomised controlled trial of the effectiveness and costeffectiveness of screening older women for the prevention of fractures: Rationale, design and methods for the SCOOP study. Osteoporos Int 2012; 23 (10) : 2507-15. http://dx.doi.org/10.1007/s00198-011-1876-7 [a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA].
87. Emmett CL, Redmond NM, Peters TJ, et al. Acceptability of screening to prevent osteoporotic fractures: A qualitative study with older women. Fam Pract 2012; 29 (2) : 235-42. http://dx.doi.org/10.1093/fampra/cmr069 .